Stefano Ferrari

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Paolo G. Casali, N. Abecassis, Sebastian Bauer et al. · Annals of Oncology · 2018 · 1.6K citations · Full text

Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Paolo G. Casali, Stefan Bielack, N. Abecassis et al. · Annals of Oncology · 2018 · 618 citations · Full text

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Alessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo et al. · The Lancet Oncology · 2017 · 473 citations

Tumor Biology, Surgical Oncology, Malignant Disease +10

Long-Term Outcome for Patients With Nonmetastatic Osteosarcoma of the Extremity Treated at the Istituto Ortopedico Rizzoli According to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 Protocol: An Updated Report

Gaetano Bacci, Stefano Ferrari, Franco Bertoni et al. · Journal of Clinical Oncology · 2000 · 446 citations

Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups

Stefano Ferrari, Sigbjørn Smeland, Mario Mercuri et al. · Journal of Clinical Oncology · 2005 · 432 citations